Rubius Therapeutics is a biopharmaceutical company based in Cambridge, Massachusetts, USA, that is developing allogeneic cell therapies based on biologically engineered red blood cells (RBCs).

When someone inherits two mutant copies of the hemoglobin gene, the abnormal form of the hemoglobin protein causes the red blood cells to lose oxygen and warp into a sickle shape during periods of ...

of the organism and controls the cell’s activities.: In the model, this is the grape. Cell membrane close cell membraneThis surrounds the outside of animal cells and controls what can enter and ...

This article from Molecular Devices explores how cell painting can be used in a 3D breast cancer spheroid model for ...

Scientists have now identified a protein that ... New Study Mapping Stem Cells Reveals Molecular Choreography Behind Individual Variation in Human Development Sep. 25, 2024 — Researchers have ...

Sep. 25, 2024 — Researchers have mapped variation in human stem cells that explains how cells of an individual may shape a unique 'developmental dance' at the ... Pigs May Be Transmission Route ...

have developed a model—called SPOT—that can predict this with a high degree of accuracy using artificial intelligence (AI). Substrates in biological cells must be continuously transported ...

Researchers in Wales and Finland have developed a new analytical model for understanding how thin-film solar cells work, Phys.org reported. The breakthrough could have major implications in ...

ChatGPT maker OpenAI has announced its next major product release: A generative AI model code-named Strawberry, officially called OpenAI o1. To be more precise, o1 is actually a family of models.

Resting brain stem cells hardly differ from normal astrocytes, which support the nerve cells in the brain. How can almost ...

The model, called Spacia, could help advance understanding of a wide range of diseases including cancers, autoimmune disorders, infectious diseases, and developmental abnormalities. "Cell-to-cell ...